Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Synthetic Biology Workshop 2017 - Panel Discussion
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
"Slowing the aging process of aging by tweaking the body’s metabolism", Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health
Erik Vogan, PhD, MBA, Program Director, MIT Corporate Relations Industrial Liaison Program
JC Gutiérrez-Ramos, President and CEO, Synlogic